TrialMatch

Sign in Sign up Create account

Search the registry

Find clinical trials

Searching 2,585 mirrored studies from ClinicalTrials.gov. Create a profile to see personalised match scores.

Filters

Clear all

2,585 studies found

Sort by

Recruiting

Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy

Phase 3 · 165 sites

Compare

Recruiting

Transpulmonary Pressure-guided Mechanical Ventilation Strategy in Right Ventricular Protection in Patients With ARDS

1 site

Compare

Recruiting

A Prospective, US-based Study Assessing Mogamulizumab-associated Rash in Patients Diagnosed With Mycosis Fungoides or Sezary Syndrome and Treated With Standard of Care Mogamulizumab

10 sites

Compare

Recruiting

Intervention for High-normal Blood Pressure in Adults With Type 2 Diabetes

Phase 4 · 1 site

Compare

Recruiting

Exploration of Health Literacy in Diabetes in Reunion Island and France

2 sites

Compare

Recruiting

The Role of the Locus Coeruleus in Age-related Distractibility

1 site

Compare

Recruiting

First in Human Study of TUB-030 in Patients With Advanced Solid Tumors

Phase 1 / Phase 2 · 20 sites

Compare

Recruiting

Pharmacopuncture for Aromatase Inhibitor Induced Arthralgia (AIA)

3 sites

Compare

Recruiting

The Efficacy and Safety of Narlumosbart in Combination With Stereotactic Body Radiation Therapy to Improve the Efficacy of First-line Chemotherapy Combined With Immunotherapy in Patients With Bone Metastases From Advanced Non-small Cell Lung Cancer

Phase 2 · 1 site

Compare

Recruiting

[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate or Salivary Gland Cancer

7 sites

Compare

Recruiting

ROMANCE: "Irinotecan Plus Cetuximab Rechallenge Versus Trifluridine/Tipiracil Plus Bevacizumab in Molecularly Selected Metastatic Colorectal Cancer"

Phase 2 · 26 sites

Compare

Recruiting

Open-label Phase 1b Study of Ulixertinib and Cetuximab or Ulixertinib in Combination With Cetuximab and Encorafenib in Patients With Unresectable or Metastatic Colorectal Cancer Who Have Previously Received EGFR or BRAF-directed Therapy

Phase 1 · 1 site

Compare

Potential match only. Final eligibility is determined by the study team.